---
document_datetime: 2023-09-21 20:36:05
document_pages: 4
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/caspofungin-accord-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
document_name: caspofungin-accord-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 2.4167371
conversion_datetime: 2025-12-29 19:52:04.611018
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Caspofungin Accord

Procedural steps taken and scientific information after the authorisation

| Application number   | Scope                                                                                                                                                                                                                                                        | Opinion/ Notification 1 issued on Product   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------|---------------------------------------------|----------------------------------|-----------|
| IB/0010              | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH | 06/02/2020                                  |                                             | SmPC                             |           |

Medicinal Product no longer authorised

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| PSUSA/576/2 01812   | Periodic Safety Update EU Single assessment - caspofungin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 11/07/2019   | n/a        | PRAC Recommendation - maintenance   |
|---------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------|------------|-------------------------------------|
| N/0008              | Minor change in labelling or package leaflet not connected with the SPC (Art. 61.3 Notification)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                | 29/04/2019   |            | Labelling                           |
| T/0007              | Transfer of Marketing Authorisation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             | 18/01/2019   | 12/02/2019 | SmPC, Labelling and PL authorised   |
| PSUSA/576/2 01612   | Periodic Safety Update EU Single assessment - caspofungin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       | 01/09/2017   | n/a longer | PRAC Recommendation - maintenance   |
| IA/0006/G           | This was an application for a group of variations. A.4 - Administrative change - Change in the name and/or address of a manufacturer or an ASMF holder or supplier of the AS, starting material, reagent or intermediate used in the manufacture of the AS or manufacturer of a novel excipient A.5.b - Administrative change - Change in the name and/or address of a manufacturer/importer of the finished product, including quality control sites (excluding manufacturer for batch release) B.I.a.3.a - Change in batch size (including batch size ranges) of AS or intermediate - Up to 10-fold increase compared to the originally approved batch size Medicinal Product | 13/07/2017   | n/a no     |                                     |
| IB/0003             | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  | 20/12/2016   | 02/06/2017 | SmPC                                |

<div style=\"page-break-after: always\"></div>

<!-- image -->

|             | assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by the MAH                                                                                                                                                                                                                                                                                            |            | authorised                       |                               |
|-------------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|----------------------------------|-------------------------------|
| IB/0004/G   | This was an application for a group of variations. A.7 - Administrative change - Deletion of manufacturing sites B.III.2.a.2 - Change of specification(s) of a former non EU Pharmacopoeial substance to fully comply with the Ph. Eur. or with a national pharmacopoeia of starting material                                                                                                                                                            | 15/12/2016 | n/a                              | a Member State - Excipient/AS |
| IB/0002     | C.I.2.a - Change in the SPC, Labelling or PL of a generic/hybrid/biosimilar products following assessment of the same change for the reference product - Implementation of change(s) for which NO new additional data is required to be submitted by                                                                                                                                                                                                     | 02/09/2016 | 02/06/2017 SmPC and PL no longer | the MAH                       |
| IAIN/0001/G | This was an application for a group of variations. B.II.b.1.a - Replacement or addition of a manufacturing site for the FP - Secondary packaging site B.II.b.2.a - Change to importer, batch release arrangements and quality control testing of the FP - Replacement/addition of a site where batch control/testing takes place B.II.b.2.c.1 - Change to importer, batch release arrangements and quality control testing of the FP - Medicinal Product | 24/06/2016 | 02/06/2017 Annex II and PL       |                               |

<div style=\"page-break-after: always\"></div>

<!-- image -->